Methods used in the clinical setting were applied to a pre-clinical study to investigate image quantification and mouse-specific dosimetry of 111In-labelled monoclonal antibodies (mAbs) targeting HER2-positive tumours. The gene discussed is ERBB2; the disease is neoplasm.